StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Core operating profit YoY CER by Quarter

Core operating profit YoY CER (%) (%)

QuarterlyAnnual

AstraZeneca Core operating profit YoY CER: 10.0% in Q2 2026, down 4.0 pts from a year earlier.

Latest, Q2 2026
10.0%
Period ended Jun 30, 2026
Change on a year earlier
-4.0 pts
14.0% in Q2 2025
History
22 quarters
Since Q4 2020
Sources
22
Documents cited below

Where the Q2 2026 figure comes from

“|| Operating profit | | 3,164 | | | 100 | | | 1,546 | | 348 | | 5,158 | 12 | 10”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Core Financial Measures.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore operating profit YoY CER (%) (%)Year on yearSource
Q2 2026Jun 30, 202610.0%-4.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202612.0%0.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-5.0%-63.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202513.0%-14.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202514.0%+13.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202512.0%-3.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202458.0%+52.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202427.0%+18.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20241.0%-38.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202415.0%+11.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20236.0%+16.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20239.0%-54.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 202339.0%-48.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20234.0%-56.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-10.0%-104.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202263.0%–Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Core operating profit YoY CER (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core-op-cer-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.